During the past decade, St. Louis University Health Sciences Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Louis University Health Sciences Center" #1 sponsor was "SWOG Cancer Research Network" with 51 trials, followed by "Radiation Therapy Oncology Group" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "Eastern Cooperative Oncology Group" with 5 trials sponsored and "CancerVax Corporation" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Louis University Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "North Central Cancer Treatment Group" with 5 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "St. Louis University Health Sciences Center" are "Lung Cancer" (16 trials), "Breast Cancer" (13 trials), "Head and Neck Cancer" (12 trials), "Leukemia" (8 trials) and "Lymphoma" (8 trials). Many other conditions were trialed in "St. Louis University Health Sciences Center" in a lesser frequency.

Most popular intervention types in "St. Louis University Health Sciences Center" are "Drug" (99 trials), "Radiation" (47 trials), "Biological" (30 trials), "Procedure" (30 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (40 trials), "cisplatin" (18 trials), "filgrastim" (16 trials), "paclitaxel" (16 trials) and "cyclophosphamide" (14 trials). Other intervention names were less common.

The vast majority of trials in "St. Louis University Health Sciences Center" are 95 trials for "All" genders, 19 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "St. Louis University Health Sciences Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 101 completed trials in St. Louis University Health Sciences Center, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in St. Louis University Health Sciences Center, 14 "Phase 1" clinical trials were conducted, 66 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".